ARCHIVES

Velcade Addition Can Improve Graft-Versus-Host Outcomes

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

Rauscher For Cancer Program

May 20, 1977

DCE Advisors OK Recompetitions Worth $10 Mil.

July 19, 1991

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

January 25, 2013

51% Control Rate Achieved In Phase II Trial of Elderly Patients

March 29, 2013

Cervarix Vaccine Approved To Prevent Cervical Cancer

October 30, 2009

Soviet Exchanges Rise And Fall With Politics

August 23, 1991